MBs(NRP2)-based ultrasound molecular imaging for early diagnosis of castration-resistant prostate cancer. Wang N, Xu X, Zhong Y, Wan Y, et al. BMC Cancer 2025;25:769.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wang N, Xu X, Zhong Y, Wan Y, et al. MBs(NRP2)-based ultrasound molecular imaging for early diagnosis of castration-resistant prostate cancer. BMC Cancer 2025;25:769.
PMID: 40275166